Clinical trialNCT01546142CompletedPhase 3Interventional

Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area

SponsorKythera BiopharmaceuticalsEnrollment516Moderate or Severe Submental Fullness

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Frederick Beddingfield, MD, PhD
Kythera Biopharmaceuticals, Inc
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

35 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

Investigational Site
Calgary, Alberta, Canada
Investigational Site
Surrey, British Columbia, Canada
Investigational Site
Vancouver, British Columbia, Canada
Investigational Site
Oakville, Ontario, Canada
Investigational Site
Woodbridge, Ontario, Canada

United States

Investigational Site
Little Rock, Arkansas, United States
Investigational Site
Beverly Hills, California, United States
Investigational Site
Los Angeles, California, United States
Investigational Site
Sacramento, California, United States
Investigational Site
San Francisco, California, United States
Investigational Site
Santa Monica, California, United States
Investigational Site
Englewood, Colorado, United States
Investigational Site
Coral Gables, Florida, United States
Investigational Site
Jacksonville, Florida, United States
Investigational Site
Chicago, Illinois, United States
Investigational Site
Naperville, Illinois, United States
Investigational Site
Carmel, Indiana, United States
Investigational Site
South Bend, Indiana, United States
Investigational Site
Lutherville, Maryland, United States
Investigational Site
Clinton Township, Michigan, United States
Investigational Site
Edina, Minnesota, United States
Investigational Site
St Louis, Missouri, United States
Investigational Site
Montclair, New Jersey, United States
Investigational Site
New York, New York, United States
Investigational Site
New York, New York, United States
Investigational Site
White Plains, New York, United States
Investigational Site
Charlotte, North Carolina, United States
Investigational Site
High Point, North Carolina, United States
Investigational Site
Cincinnatti, Ohio, United States
Investigational Site
Portland, Oregon, United States
Investigational Site
Austin, Texas, United States
Investigational Site
Plano, Texas, United States
Investigational Site
San Antonio, Texas, United States
Investigational Site
Salt Lake City, Utah, United States
Investigational Site
Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2012
Primary completion: 31 May 2013
Completion: 31 Aug 2013
Last update posted: 15 Jun 2015
Registered enrollment: 516
Registry id: NCT01546142

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.